Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.
Van Not OJ, van den Eertwegh AJM, Haanen JB, van Rijn RS, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, van Eijs MJM, de Groot JB, Hospers GAP, Kapiteijn E, de Meza M, Piersma D, Stevense-den Boer M, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Suijkerbuijk KPM, Blokx WAM.
Van Not OJ, et al. Among authors: haanen jb.
Eur J Cancer. 2023 Jun;186:27-37. doi: 10.1016/j.ejca.2023.03.009. Epub 2023 Mar 16.
Eur J Cancer. 2023.
PMID: 37023588
Free article.